BIO18: Pfizer's Bourla on volume vs. value

BIO18: Pfizer's Bourla on volume vs. value

Source: 
Biopharma Dive
snippet: 

'Patient-centricity' has been a buzzword in the pharmaceutical industry for the last decade, but Pfizer's Chief Operating Officer Albert Bourla contends the advent of new technologies has finally made this far-flung concept a reality.